Bioequivalence Study of 20 mg Tadalafil Film Coated Tablets, Manufactured by PT. Lapi Laboratories (Tadalafil LAPI) in Comparison with the Innovator’s Film Coated Tablets (Cialis®), Manufactured by Lilly del Caribe Inc., Puerto Rico for Lilly S.A. Alcobendas, Madrid – Spain, Registered by PT. Bayer Indonesia, Depok, Indonesia
Tahapan Penelitian : Complete
Sponsor:
PT Lapi Laboratories
Mitra Pelaksana:
Econolab
No Registry
INA-4DG6K4T
Tanggal Input Registry : 09-02-2024
| Tracking Information | |
|---|---|
| Tanggal Antisipasi Studi | 30-11-2019 |
| Outcome Primer | AUC-t and Cmax |
| Outcome Skunder | AUC0-t, Tmax, T1/2 |
| Descriptive Information | |
| Judul Penelitian Popular | Bioequivalence Study of 20 mg Tadalafil Film Coated Tablets, Manufactured by PT. Lapi Laboratories (Tadalafil LAPI) in Comparison with the Innovator’s Film Coated Tablets (Cialis®), Manufactured by Lilly del Caribe Inc., Puerto Rico for Lilly S.A. Alcobendas, Madrid – Spain, Registered by PT. Bayer Indonesia, Depok, Indonesia |
| Judul Penelitian Ilmiah | Bioequivalence Study of 20 mg Tadalafil Film Coated Tablets, Manufactured by PT. Lapi Laboratories (Tadalafil LAPI) in Comparison with the Innovator’s Film Coated Tablets (Cialis®), Manufactured by Lilly del Caribe Inc., Puerto Rico for Lilly S.A. Alcobendas, Madrid – Spain, Registered by PT. Bayer Indonesia, Depok, Indonesia |
| Jenis Penelitian | Interventional |
| Intervensi | Single dose of one film coated tablet of 20 mg Tadalafil (Tadalafil LAPI), Manufactured PT Lapi Laboratories |
| Jumlah Subyek Penelitian | 14 |
| Recruitment Information | |
| Eligibility Criteria | Inclusion Criteria: Able to participate, communicate well with the investigators and agree to sign an informed consent, healthy male subjects as determined by the medical screening assessments; Aged 18-55 years of age; Body mass index (BMI) is in the range of 18-25 kg/m²; Systolic blood pressure:100-120 mmHg; Diastolic blood pressure: 60-80 mmHg; Pulse rate 60-90 bpm; Normal electrocardiogram (ECG); Clinical laboratory results have to be within normal range. Medical judgement of responsible physician will determine any laboratory finding beyond its standard value.Exclusion Criteria: Consuming organic nitrate drug class; Known hypersensitivity or contraindication to the study drug; intake of any prescription drug or non-prescription drug/food supplement/herbal medicine within 7 days of this study’s first dosing day; History of any bleeding or coagulation disorders; Any surgical or medical condition (present or history) which might significantly alters the absorption, distribution, metabolism or excretion of the study drug, e.g. gastrointestinal diseases including gastric or duodenal ulcers or history of gastric surgery; A donation or loss of 300 mL (or more) of blood within 3 months before this study’s first dosing day; A positive Hepatitis B surface antigen (HBsAg), HCV, HIV test result; History of drug or alcohol abuse within 12 months prior to this study; Heavy Smoker (more than 10 cigarettes a day); Clinically have significant bleeding within 3 months prior to the study; Participation in a previous study within 3 months of this study’s first dosing day. |
| Administrative Information | |
| Nomor Persetujuan Etik | 0016/UN2.F1/ETIK/2019 |
| Nomor Persetujuan Material Transfer Agreement | Not applicable |
| Nomor Persetujuan Pelaksanaan Uji Klinik | PPUK/PPUB number |
| Other Study ID Numbers | PRO-235/18/ECL |
| Contact Person | Ni Made Dwi Wulandari |